Research and Markets
announced the addition of the “European Markets for Coronary Artery Bypass Graft
Devices 2009″ report to their offering.
Through 2013, the market for coronary artery bypass graft (CABG) devices in
Europe will be driven largely by an increase in procedure volumes caused by
rising rates of coronary artery disease (CAD) and a growing need for repeat
revascularization procedures. Although the market will be limited by less
invasive alternative treatments, such as medical managment and percutaneous
coronary interventions, growing adoption of endoscopic vessel harvesting (EVH)
devices and anastomosis assist devices (AADs) will further support revenue
growth over the forecast period.
Questions Answered in This Report:
The global economic downturn beginning in late 2008 had a broad impact on
European CABG device markets. How have budget restrictions affected the
replacement rate of capital equipment required for CABG procedures? How long
will this impact continue to be felt in the CABG device market?
Cardiac surgeons across Europe are increasingly opting for off-pump coronary
artery bypass (OPCAB) over on-pump coronary artery bypass (ONCAB) methods. How
rapidly is this shift occuring? Will OPCAB completely replace ONCAB? For which
patient subgroups might ONCAB still have a role?
Treatment of CAD by CABG is in direct competition with interventional cardiology
methods. What clinical studies are affecting physicians’ choices? How will the
introduction and adoption of EVH and minimally invasive CABG devices affect this
The competitive landscape of the European CABG device market is highly dynamic.
How have companies used acquisitions to reshape or expand their portfolios? How
do the competitive landscapes of the covered countries differ?
Regions covered: France, Germany, Italy, and the UK
Segmentation: Our analysis uses the following segmentation of the market:
* Cardiac surgery labs
* ONCAB devices
* – Disposable perfusion devices (custom perfusion pack and stand-alone:
arterial filters, cardioplegia systems, centrifugal blood pumps,
hemoconcentrators, oxygenators, reservoirs, mini-bypass circuits, and cannulae)
* – Capital equipment (cardiopulmonary bypass machines and centrifugal pump
* OPCAB devices
* – Primary devices (stabilizers, positioners, and OPCAB kits)
* – Accessories (blowers/misters and coronary shunts)
* EVH devices
* – Saphenous vein procedures
* – Radial artery procedures
* – Proximal (hemostatic seal systems and automated graft delivery system)
* – Distal
Market forecast features: Based on primary research with industry professionals,
we use our proprietary forecasting model to provide an in-depth examination of
current and future trends in procedure volumes, unit sales, average selling
prices, and market values over a 7-year period (20072013).
Competitive analysis: We provide a detailed analysis of the competitive
landscape in the market, as well as market shares and qualitative discussions of
the leading competitors in each market segment.
Key Topics Covered:
TABLE OF CONTENTS
LIST OF EXHIBITS
1.0 EUROPEAN CORONARY ARTERY BYPASS GRAFT DEVICE MARKET
2.0 ON-PUMP CORONARY ARTERY BYPASS DEVICE MARKET
3.0 OFF-PUMP CORONARY ARTERY BYPASS DEVICE MARKET
4.0 ENDOSCOPIC VESSEL HARVESTING DEVICE MARKET
5.0 ANASTOMOSIS ASSIST DEVICE MARKET
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: SUPPLEMENTAL EXHIBITS
For more information visit
Source: Millennium Research Group
Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Copyright Business Wire 2010